Literature DB >> 15346250

Natural history and management of hepatitis C infection after liver transplantation.

Michael Charlton1, Russell Wiesner.   

Abstract

With almost universal virological recurrence and a projected several-fold increase in HCV-related end-stage liver disease within the next decade, a clear understanding of the natural history of posttransplant HCV infection and optimization of the management of recurrent HCV infection are imperative. This article describes the natural history, risk factors, and current strategies for the amelioration of posttransplant HCV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15346250     DOI: 10.1055/s-2004-832932

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  7 in total

1.  New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation.

Authors:  A Sidney Barritt; Jama M Darling; Paul H Hayashi
Journal:  Curr Hepat Rep       Date:  2011-09

2.  A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation.

Authors:  Gregory T Everson; Norah A Terrault; Anna S Lok; Del R Rodrigo; Robert S Brown; Sammy Saab; Mitchell L Shiffman; Abdullah M S Al-Osaimi; Laura M Kulik; Brenda W Gillespie; James E Everhart
Journal:  Hepatology       Date:  2013-01-17       Impact factor: 17.425

3.  Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.

Authors:  Brian B Borg; Anil Seetharam; Vijay Subramanian; Haseeb Ilias Basha; Mauricio Lisker-Melman; Kevin Korenblat; Christopher D Anderson; Surendra Shenoy; William C Chapman; Jeffrey S Crippin; Thalachallour Mohanakumar
Journal:  Liver Transpl       Date:  2011-07       Impact factor: 5.799

4.  R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins.

Authors:  Robert A Brown; Jonathon H Gralewski; Albert J Eid; Bettina M Knoll; Robert W Finberg; Raymund R Razonable
Journal:  Transplantation       Date:  2010-04-15       Impact factor: 4.939

5.  Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response.

Authors:  Kathie-Anne Walters; Michael A Joyce; Jill C Thompson; Maria W Smith; Matthew M Yeh; Sean Proll; Lin-Fu Zhu; T J Gao; Norman M Kneteman; D Lorne Tyrrell; Michael G Katze
Journal:  PLoS Pathog       Date:  2006-06-23       Impact factor: 6.823

Review 6.  Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis.

Authors:  Yaqin Chen; Gang Wu; Hongmin Zhang; Hua Xu; Hong Li; Ling Chen; Yixuan Yang; Peng Hu; Dazhi Zhang; Hong Ren; Huaidong Hu
Journal:  Gastroenterol Res Pract       Date:  2015-06-16       Impact factor: 2.260

7.  Quality of life 10 years after liver transplantation: The impact of graft histology.

Authors:  Vincent Karam; Mylène Sebagh; Kinan Rifai; Funda Yilmaz; Prashant Bhangui; Colette Danet; Faouzi Saliba; Didier Samuel; Denis Castaing; René Adam; Cyrille Feray
Journal:  World J Transplant       Date:  2016-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.